LifeTech Scientific Corp (hkse:01302) Share Price

Company Profile

Business description
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
Contact
No. 22, Keji 12th Road South
14th Floor, LifeTech Scientific Building
High-tech Industrial Park
Nanshan District
Shenzhen518063
CHN
T: +86 75586026250
http://www.lifetechmed.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
1,254

Recommended

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Jacob Robbins | 21 September 2026

Morningstar analysts’ take on the takeover for this undervalued industrial player.

Esther Holloway | 20 September 2026

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.

Tyger Fitzpatrick | 20 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,919.10	3.60	-0.04%
CAC 40	8,112.46	47.44	0.59%
DAX 40	25,472.81	168.75	0.67%
Dow JONES (US)	51,682.64	95.40	-0.18%
FTSE 100	10,704.78	45.65	0.43%
HKSE	24,995.34	244.56	0.99%
NASDAQ	26,522.54	104.25	0.39%
Nikkei 225	65,018.95	882.70	1.38%
NZX 50 Index	13,821.20	82.06	0.60%
S&P 500	7,650.50	12.74	0.17%
S&P/ASX 200	8,731.90	0.70	0.01%
SSE Composite Index	3,949.91	38.04	0.97%